You’ll perform adrenal vein sampling (AVS) to pinpoint aldosterone production from each adrenal gland. During the catheter‑based procedure, you’ll collect blood from both adrenal veins and a peripheral jugular sample, then compute aldosterone‑to‑cortisol ratios. If the lateralization index exceeds 4 with high selectivity, it confirms unilateral disease and guides you toward laparoscopic adrenalectomy for cure. Bilateral elevation points to medical therapy with spironolactone or eplerenone. Curious about precision techniques and recent success rates? Further insights await.

Key Takeaways

• AVS differentiates unilateral versus bilateral aldosterone secretion by sampling each adrenal vein and the IVC, measuring aldosterone/cortisol ratios.
• Selectivity index > 2 (unstimulated) or > 5 (with ACTH) confirms proper adrenal cannulation; otherwise the result is non‑diagnostic.
• Lateralization index > 4 with cosyntropin (or > 2–3 unstimulated) indicates unilateral disease; a lower LI plus contralateral suppression (CSI < 1) confirms surgical candidacy.
• Bilateral hyperplasia shows LI below threshold and CSI ≥ 1, guiding medical therapy rather than surgery.
• High‑volume centers using cone‑beam CT and metoclopramide improve cannulation success > 95 % and achieve higher surgical cure rates.

What Is Adrenal Vein Sampling and Why Is It Needed

What exactly is adrenal vein sampling (AVS), and why does it matter for treating primary aldosteronism? AVS is a minimally invasive, catheter‑based test that samples blood from both adrenal veins and compares hormone levels to peripheral circulation. You’ll see that the procedure requires an interventional radiologist in a dedicated angiography suite. By measuring aldosterone and cortisol from each vein, you calculate a selectivity index to confirm successful catheter placement and a lateralization index to determine whether the excess hormone originates from one side or both. This functional insight is the diagnostic necessity that anatomy‑only imaging cannot provide, because incidentalomas may be non‑functional and small adenomas can be missed on CT or MRI. Guideline‑based evidence shows that AVS leads to appropriate surgical referral for unilateral disease and spares patients from unnecessary adrenalectomies when bilateral hyperplasia is present. These results shape your treatment plan and improve outcomes substantially.

Who Should Undergo AVS? Age, Imaging, and Biochemical Triggers

After seeing how AVS definitively distinguishes unilateral from bilateral aldosterone excess, the next clinical question is patient selection. To decide who should undergo sampling, you rely on consensus guidelines, age thresholds, imaging necessity, and biochemical triggers.

Determining AVS candidates hinges on guidelines, age, imaging, and biochemical triggers.

1. Age thresholds: No hard upper limit exists; instead assess physiological age and comorbidities. Patients under 35 with a clear adenoma may skip AVS, while older adults require risk–benefit assessment.
2. Imaging necessity: CT or MRI must precede AVS to map anatomy and exclude carcinoma, yet imaging alone is insufficient—discordance reaches 38%.
3. Biochemical triggers: Confirmed PA on saline or captopril tests, hypokalemia, resistant hypertension, or an early onset (<30 years) all warrant AVS.

Age and frailty determine whether surgery AVS is beneficial. Familial hyperaldosteronism suggests bilateral disease; AVS is seldom performed unless atypical findings arise. Imaging does not exclude unilateral secretion; biochemical confirmation remains essential.

Step‑by‑Step: The AVS Procedure in the Operating Room

During adrenal vein sampling (AVS), you position the patient supine on the angiography table, establish intravenous access, and administer conscious sedation to allow real‑time cooperation while continuously monitoring blood pressure and heart rate. You then introduce a femoral venous sheath—typically via the right groin—to securely and quickly secure catheter access. Under fluoroscopic guidance, you advance a catheter into the inferior vena cava, carefully directing toward the right adrenal vein. You inject contrast to opacify the right vein, then confirm cannulation with venography. Next, you cannulate the left adrenal vein draining into the left renal vein, verifying with contrast dye. Simultaneously, you draw blood samples from both adrenal veins and a IVC line before ACTH stimulation. After ACTH administration, you repeat sampling and label each specimen with time stamps. Once final samples are collected, you remove the catheter and sheath, achieving hemostasis with compression or a closure device.

Interpreting the Numbers: Selectivity and Lateralization Indices Explained

Concluding the catheterization phase, you immediately calculate the selectivity index (SI) to confirm that each adrenal vein was cannulated correctly. An SI > 2:1 (unstimulated) or > 5 after cosyntropin reliably signals successful sampling; failing to reach these thresholds indicates Selectivity Breakdowns and renders the dataset non‑diagnostic.

After catheterization, compute the SI; >2 unstimulated or >5 with cosyntropin confirms success, otherwise data is non‑diagnostic.

You then compute the Lateralization Index (LI) to pinpoint unilateral excess:

1. LI = (aldosterone/cortisol on dominant side) ÷ (aldosterone/cortisol on non‑dominant side).
2. If the LI exceeds the established Lateralization Thresholds (typically > 4:1 with stimulation, > 2–3 unstimulated), you diagnose unilateral primary aldosteronism.
3. Verify contralateral suppression: a CSI < 1 further confirms unilateral disease and predicts surgical cure.

If the LI falls below thresholds and CSI ≥ 1, you interpret the findings as bilateral hyperplasia and steer patients toward mineralocorticoid antagonist therapy.

Throughout this calculation, maintain precision; small deviations can shift interpretation, so repeat sampling if values hover near the cutoffs.

Documenting each numeric step reinforces reproducibility and supports review before finalizing treatment.

Clinical Decision‑Making: Unilateral vs. Bilateral Disease & Treatment Paths

Because adrenal vein sampling (AVS) remains the gold standard for determining disease laterality, the step that follows the catheterization is a decisive one: you must interpret the lateralization index (LI) and contralateral suppression (CLS) to decide between surgical resection and lifelong medical therapy. A LI > 4 with CLS confirms unilateral adenoma and justifies laparoscopic adrenalectomy, offering biochemical cure in nearly 100 % of cases and often blood‑pressure remission. Before surgery, you should optimize mineralocorticoid‑receptor antagonist therapy to stabilize potassium and hypertension. If CLS is absent or the LI falls below threshold, bilateral adrenal hyperplasia is likely, steering you toward lifelong MRA therapy—spironolactone or eplerenone—to control blood pressure and normokalemia. Weigh each patient’s surgical risk and medication burden against potential cure, and plan rigorous follow‑up to monitor recurrence or complications. Additionally, address comorbidities like cardiovascular disease, which can influence both surgical outcomes and the need for adjustments.

Choosing a Center and Current Advancements in AVS

When patient outcomes hinge on procedural success, the choice of an AVS center becomes pivotal. You depend on center volume and protocol updates to drive precision. Focus on these key elements:

1. Multidisciplinary team with >50 AVS procedures annually, including the interpreting radiologist.
2. On‑site rapid cortisol assays plus optional cosyntropin stimulation.
3. Integrated adrenalectomy and medical management within the same institution.

High‑volume centers achieve >95 % successful cannulation, whereas low‑volume centers reach ~40 %. Cone‑beam CT guidance, ultrasensitive cortisol testing, and metoclopramide options further reduce time and radiation. Centralizing AVS aligns with guidelines and creates a data‑driven pipeline that improves lateralization accuracy and surgical cure rates. Choose a center that upholds these standards, and you’ll secure the best possible outcome for patients with primary aldosteronism, boosting confidence and precision. By selecting a high‑volume, protocol‑updated expert center, you reduce procedural complications, enhance diagnostic confidence, and ultimately improve long‑term blood pressure control with care.

Frequently Asked Questions

What Insurance Coverage Is Available for Adrenal Vein Sampling?

You can typically secure coverage when you’ll follow a strict claim strategy that meets Medicare, private, and Medicaid criteria. Coverage insight shows insurers require a documented positive aldosterone‑renin ratio, a recent adrenal CT or MRI, and corrected potassium levels before approving the CPT 75893 procedure. Present a pre‑authorization packet, cite endocrine society guidelines, and perform the sampling at an accredited center to maximize acceptance for your treatment plan now.

Can AVS Be Performed Safely During Pregnancy?

Yes, AVS can be safely performed during pregnancy when you follow strict pregnancy protocol, use safety measures, and limit radiation. You position the patient laterally, keep fluoroscopy time minimal, employ pulsed fluoroscopy, collimation, and shielding, and map the adrenal veins with non‑contrast MRI. You adjust selectivity and lateralization indices, and you reserve AVS for severe, resistant hypertension only, ideally in the second trimester and you monitor fetal heart rate continuously.

Are There Alternative Tests if a Center Lacks AVS Expertise?

If your center lacks AVS expertise, you’ll turn to high‑resolution imaging. CT angiography provides 78% sensitivity for unilateral PA, while MRI assessment offers comparable accuracy. Use strict criteria—age 1 cm hypodense nodule, normal contralateral gland—to guide surgery. However, this approach risks 25% misdiagnosis, so consider medical therapy or referral when imaging findings are equivocal. Primarily, clinicians should balance diagnostic certainty against surgical risk and improve long‑term outcomes today.

How Long Does Reimbursement Take After an AVS Procedure?

You’re probably worried the wait feels endless, but the timeline is predictable. After an AVS procedure, the claim cycle averages 45 to 90 days from procedure date to payment receipt. Medicare often clears clean claims within 14–30 days, while private insurers cycle 30–45 days. Precise coding, pre‑authorization, and electronic submission cut delays, ensuring a steady processing time and that consistency gives clinicians confidence in financial planning and follows your practice.

Is AVS Necessary for Patients With Prior Adrenal Surgery?

Yes, AVS is often essential for patients after adrenal surgery. Because resected tissue can leave a remnant capable of adrenal regrowth, you’ll need to assess whether residual gland is producing excess aldosterone or if contralateral hyperplasia has developed. A post‑operative AVS reliably identifies unilateral versus bilateral disease, guiding repeat surgery or medical therapy, and improves blood‑pressure outcomes after revision, imaging alone may miss subtle dysfunction, and AVS clarifies the source.

Conclusion

Imagine you’re a 46‑year‑old woman with resistant hypertension and a 2‑cm adrenal adenoma identified on CT. Your adrenal vein sampling shows a lateralization index of 4.8 on the left side, confirming unilateral aldosterone excess. Treatment with left adrenalectomy reduces plasma aldosterone to normal and improves blood‑pressure control, illustrating how precise AVS guides successful, organ‑preserving care in primary aldosteronism. That’s the power of evidence‑based localization, and aligns outcome metrics with guideline‑based practice for patient safety.